The Impact of Pharmacist Recommendations on Quality of Care in Diabetic Patients
1 other identifier
interventional
300
1 country
1
Brief Summary
The goal of this study is to investigate a comprehensive provider-focused intervention to improve the quality of care for diabetic patients in a large primary care practice at Brigham and Women's Hospital. This will be accomplished through pharmacist recommendations provided to primary care providers prior to routine scheduled office visits for diabetic patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable diabetes-mellitus
Started Jun 2003
Longer than P75 for not_applicable diabetes-mellitus
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2003
CompletedFirst Submitted
Initial submission to the registry
July 19, 2005
CompletedFirst Posted
Study publicly available on registry
July 22, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2010
CompletedFebruary 20, 2012
February 1, 2012
6.7 years
July 19, 2005
February 17, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Compliance with process measures at 30 days after the index primary care visit
aspirin use, ace inhibitor use, a1c measurement
30 days
Secondary Outcomes (1)
Percentage of pharmacist recommendations accepted by primary care providers within 30 days after index visit
30 days
Study Arms (2)
pharmacist recommendation
ACTIVE COMPARATORrecommendations based on chart review by pharmacist, given to pcp at time of visit
usual care
NO INTERVENTIONusual care
Interventions
recommendations based on chart review by pharmacist, given to pcp at time of visit
recommendations based on chart review by pharmacist, given to pcp at time of visit
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of diabetes
- Age 18 years or older
- Identifiable primary care physician (PCP)
- Attendance at index appointment with PCP
You may not qualify if:
- No assigned PCP
- Non-attendance at PCP appointment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rebecca J Cunningham, MD
Brigham and Women's Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
July 19, 2005
First Posted
July 22, 2005
Study Start
June 1, 2003
Primary Completion
February 1, 2010
Study Completion
February 1, 2010
Last Updated
February 20, 2012
Record last verified: 2012-02